Showing results (431-440 of 870) with videos related to
Sort By:
Pageof 87
Kidney Research and Clinical Practice|June 16, 2026
Clinical significance of genetic mutations in adult patients with focal segmental glomerulosclerosisMin Min, Qiuxia Wang, Lina Zhu, et al.Kidney Research and Clinical Practice|June 16, 2026
Impact of acute kidney injury labeling strategies in hospitalized patients: suggestion for a dual-alert clinical decision support systemSe-Jin Ahn, Nam-Jun Cho, Inyong Jeong, et al.Kidney Research and Clinical Practice|July 8, 2026
Remission of hematuria is associated with a better prognosis in immunoglobulin A nephropathyGeo Neul Park, MinSung Lee, Seon Min Kim, et al.Kidney Research and Clinical Practice|September 3, 2019
Proximal renal tubular acidosis with and without Fanconi syndromeIbrahim Kashoor, Daniel BatlleKidney Research and Clinical Practice|July 28, 2026
Renin-angiotensin system blockade in diabetic kidney disease: an old pillar that still stands at the core of therapyDong Hoon Kang, Tae-Hyun Yoo, Kidney Research and Clinical Practice|July 31, 2026
Glomerular hyperfiltration in dipstick-negative type 2 diabetes mellitus: a novel determinant of kidney function decline in type 2 diabetes mellitusDughyun Choi, Samel Park, Dong-Sub Kim, et al.Kidney Research and Clinical Practice|August 4, 2026
Rationale and design of the EXCELSIOR-CKD trial: intensive blood pressure and lipid control in advanced chronic kidney diseaseYaerim Kim, Jwa-Kyung Kim, Gang-Jee Ko, et al.Kidney Research and Clinical Practice|August 7, 2026
Machine learning-assisted prediction of 5-year mortality in chronic kidney disease: the KoreaN cohort study for Outcome in patients With Chronic Kidney Disease (KNOW-CKD)Sang Heon Suh, Hong Sang Choi, Chang Seong Kim, et al.Kidney Research and Clinical Practice|August 20, 2026
FOXO4 enhances high glucose-induced HK-2 cell damage and inflammation by targeting TFPI2 in diabetic nephropathyLiqin Mu, Yu Zhao, Yang Li, et al.Kidney Research and Clinical Practice|August 13, 2026
Beyond current standards: combination therapy and emerging targets in diabetic kidney diseaseJiwon Lee, Mi-Yeon Yu, Pageof 87